Digital Ally, Inc. Reschedules Time of Second Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Digital Ally, Inc. Reschedules Time of Second Quarter Conference Call to 4:15 P.M. EDT Today -- Wednesday, July 24, 2013

LENEXA, KS--(Marketwired - Jul 24, 2013) - Digital Ally, Inc. ( NASDAQ : DGLY ), which develops, manufactures and markets advanced digital technology products for law enforcement, homeland security and commercial security applications, today announced that the time of the Company's investor conference call to discuss its operating results for the second quarter and first half of 2013 has been changed to 4:15 p.m. Eastern Time today, Wednesday, July 24, 2013. The Company's operating results were reported in a press release after the market closed on July 23, 2013.

Shareholders and other interested parties may participate in the conference call by dialing 877-374-8416 (international participants dial 412-317-6716) and asking to be connected to the "Digital Ally, Inc. Conference Call" a few minutes before 4:15 p.m. EDT today -- July 24, 2013. 

A replay of the conference call will be available one hour after the completion of the conference call from July 24, 2013 until 9:00 a.m. on September 25, 2013 by dialing 877-344-7529 (international participants dial 412-317-0088) and entering the conference ID # 10031724. 

About Digital Ally, Inc.

Digital Ally, Inc. develops, manufactures and markets advanced technology products for law enforcement, homeland security and commercial applications. The Company's primary focus is digital video imaging and storage. For additional information, visit www.digitalallyinc.com

The Company is headquartered in Lenexa, Kansas, and its shares are traded on The Nasdaq Capital Market under the symbol "DGLY".

For Additional Information, Please Contact: Stanton E. Ross CEO (913) 814-7774 or RJ Falkner & Company, Inc. Investor Relations Counsel (800) 377-9893 info@rjfalkner.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Valour Inc. Unveils Advanced Leveraged ETPs for Crypto Trading

Updated Category News Views 86

Valour Inc. Launches Innovative Leveraged ETPs Valour Inc., a subsidiary of DeFi Technologies, is making waves in the financial technology sector by launching leveraged exchange-traded products (ETPs) focused on Bitcoin and Ethereum. These new offerings, titled Bull Bitcoin X2 Valour and Bull Ethereum X2 Valour, deliver twice the daily exposure to these leading...

Continue Reading
Inhibikase Therapeutics Makes Headway with $275 Million Financing

Updated Category News Views 84

Introduction to Inhibikase Therapeutics Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is a pioneering clinical-stage pharmaceutical company dedicated to creating innovative therapeutics for cardiopulmonary and neurodegenerative diseases. Their commitment to developing high-quality treatments is evident in the recent announcement regarding an impressive financing deal....

Continue Reading
JBS USA Food Company's Successful Tender Offer for Notes

Updated Category News Views 341

Overview of the Tender Offer by JBS USA Food Company JBS USA Food Company recently shared exciting news about the successful conclusion of its cash tender offer for its 2.500% Senior Notes due 2027. The offer was designed for any and all outstanding notes, aimed at strengthening the company's financial position. Details on Tender Offer Results As reported, the results...

Continue Reading
Imaflex's Impressive Q2 2025 Results Show Resilience

Updated Category News Views 114

Strong Balance Sheet and Operational Agility Support Future Growth In a world where market dynamics can shift unexpectedly, Imaflex Inc. is finding ways to maintain robust performance despite the prevailing challenges. The company recently released its financial results for the second quarter of 2025 with notable highlights that showcase its resilience and strategic...

Continue Reading
A Decade of Growth: The Journey of Penumbra Stock Value

Updated Category News Views 158

Understanding Penumbra's Growth Over the Last Decade Penumbra (NYSE: PEN) has shown remarkable growth over the past decade, achieving an annualized return of 20.49%. This performance eclipses the market by an impressive 7.83% annually, making it a notable player in the healthcare sector. The Impact of Compounding Returns When it comes to investing, one fundamental...

Continue Reading